Homework Help is Here – Start Your Trial Now!
Math
Statistics
d) Company A says that it has provided 138 patents, of which 45 were successful, giving a success rate of 32.6%. The corresponding figure for Company B is 30.7%. How would Company B respond to this claim? O A. Company B would respond that Company A's overall success rate is greater because Company A has submitted a higher volume of patent requests. O B. Company B would respond that Company A's overall success rate is greater because Company A's patent requests are subjected to a more lenient approval process. O C. Company B would respond that Company A's overall success rate is greater because it focuses on anti-inflammatory drug patents whose overall success rate is higher than the success rate for other drug patents. O D. Company B would respond that Company A's overall success rate is greater because Company B has yet to submit a new batch of patent requests for which it expects a high success rate for all drug types. e) (i) If the pharmaceutical company wants to buy a patent, which biotechnology company is better for genetic disease drugs? The pharmaceutical should buy the patent from Company because it has a success rate with genetic disease drugs of which is greater than the other company. (Deund

d) Company A says that it has provided 138 patents, of which 45 were successful, giving a success rate of 32.6%. The corresponding figure for Company B is 30.7%. How would Company B respond to this claim? O A. Company B would respond that Company A's overall success rate is greater because Company A has submitted a higher volume of patent requests. O B. Company B would respond that Company A's overall success rate is greater because Company A's patent requests are subjected to a more lenient approval process. O C. Company B would respond that Company A's overall success rate is greater because it focuses on anti-inflammatory drug patents whose overall success rate is higher than the success rate for other drug patents. O D. Company B would respond that Company A's overall success rate is greater because Company B has yet to submit a new batch of patent requests for which it expects a high success rate for all drug types. e) (i) If the pharmaceutical company wants to buy a patent, which biotechnology company is better for genetic disease drugs? The pharmaceutical should buy the patent from Company because it has a success rate with genetic disease drugs of which is greater than the other company. (Deund

Linear Algebra: A Modern Introduction
Linear Algebra: A Modern Introduction
4th Edition
ISBN:9781285463247
Author:David Poole
Publisher:David Poole
Chapter2: Systems Of Linear Equations
Section2.4: Applications
Problem 3EQ: A florist offers three sizes of flower arrangements containing roses, daisies, and chrysanthemums....
See similar textbooks
icon
Related questions
Question

8

Number of patents Company A Successful Unsuccessful Successful Unsuccessful Company B Number of Patents Genetic Diseases Chemotherapy Anti-inflammatory Total 15 12 32 28 12 35 37 50 11 12 45 93 35 79 Print Done
Transcribed Image Text:Number of patents Company A Successful Unsuccessful Successful Unsuccessful Company B Number of Patents Genetic Diseases Chemotherapy Anti-inflammatory Total 15 12 32 28 12 35 37 50 11 12 45 93 35 79 Print Done
Small biotechnology companies are research intensive and develop chemical compounds that may prove to be useful drugs. A pharmaceutical company has been buying patents from two biotechnology companies. The numbers of patents that led to successful and unsuccessful drugs during the past five years for three categories of drug are in the accompanying table. Complete parts (a) through (e). Click the icon to view the numbers of patents. ... d) Company A says that it has provided 138 patents, of which 45 were successful, giving a success rate of 32.6%. The corresponding figure for Company B is 30.7%. How would Company B respond to this claim? O A. Company B would respond that Company A's overall success rate is greater because Company A has submitted a higher volume of patent requests. O B. Company B would respond that Company A's overall success rate is greater because Company A's patent requests are subjected to a more lenient approval process. OC. Company B would respond that Company A's overall success rate is greater because it focuses on anti-inflammatory drug patents whose overall success rate is higher than the success rate for other drug patents. O D. Company B would respond that Company A's overall success rate is greater because Company B has yet to submit a new batch of patent requests for which it expects a high success rate for all drug types. e) (i) If the pharmaceutical company wants to buy a patent, which biotechnology company is better for genetic disease drugs? The pharmaceutical should buy the patent from Company because it has a success rate with genetic disease drugs of , which is greater than the other company. (Round to three decimal places as needed.)
Transcribed Image Text:Small biotechnology companies are research intensive and develop chemical compounds that may prove to be useful drugs. A pharmaceutical company has been buying patents from two biotechnology companies. The numbers of patents that led to successful and unsuccessful drugs during the past five years for three categories of drug are in the accompanying table. Complete parts (a) through (e). Click the icon to view the numbers of patents. ... d) Company A says that it has provided 138 patents, of which 45 were successful, giving a success rate of 32.6%. The corresponding figure for Company B is 30.7%. How would Company B respond to this claim? O A. Company B would respond that Company A's overall success rate is greater because Company A has submitted a higher volume of patent requests. O B. Company B would respond that Company A's overall success rate is greater because Company A's patent requests are subjected to a more lenient approval process. OC. Company B would respond that Company A's overall success rate is greater because it focuses on anti-inflammatory drug patents whose overall success rate is higher than the success rate for other drug patents. O D. Company B would respond that Company A's overall success rate is greater because Company B has yet to submit a new batch of patent requests for which it expects a high success rate for all drug types. e) (i) If the pharmaceutical company wants to buy a patent, which biotechnology company is better for genetic disease drugs? The pharmaceutical should buy the patent from Company because it has a success rate with genetic disease drugs of , which is greater than the other company. (Round to three decimal places as needed.)
Expert Solution
steps

Step by step

Solved in 2 steps

SEE SOLUTIONCheck out a sample Q&A here
Blurred answer
Recommended textbooks for you
Linear Algebra: A Modern Introduction
Linear Algebra: A Modern Introduction
Algebra
ISBN:
9781285463247
Author:
David Poole
Publisher:
Cengage Learning
College Algebra
College Algebra
Algebra
ISBN:
9781938168383
Author:
Jay Abramson
Publisher:
OpenStax
College Algebra
College Algebra
Algebra
ISBN:
9781305115545
Author:
James Stewart, Lothar Redlin, Saleem Watson
Publisher:
Cengage Learning
Algebra and Trigonometry (MindTap Course List)
Algebra and Trigonometry (MindTap Course List)
Algebra
ISBN:
9781305071742
Author:
James Stewart, Lothar Redlin, Saleem Watson
Publisher:
Cengage Learning
SEE MORE TEXTBOOKS